Insider sells 28,826 shares; option exercise noted

CTNM reported Form 144 sales by an insider on 06/30/2026 and earlier dates.

Rhea-AI Filing Summary

CTNM reported Form 144 sales by an insider on 06/30/2026 and earlier dates. The filing lists multiple 10b5-1 plan sales: 28,826 shares on 06/30/2026 for $462,288.02; 4,170 shares on 06/01/2026 for $54,862.19; 4,170 shares on 05/01/2026 for $54,707.48; and 4,170 shares on 04/06/2026 for $56,013.94. The filing also records an exercise of stock options of 5,350 shares on 07/01/2026 and 4,170 restricted stock units dated 05/09/2017.

Insights

Securities Counsel

Form 144 documents scheduled/resale transactions under a 10b5-1 plan and an option exercise.

The filing lists multiple 10b5-1 plan sales totaling reported shares and dollar amounts, with the largest single entry of 28,826 shares on 06/30/2026 for $462,288.02. It also records an option exercise of 5,350 shares on 07/01/2026.

These entries are routine disclosure of a selling arrangement and an exercise; cash‑flow treatment and any lockup or broker details are not provided in the excerpt. Subsequent filings or broker reports would show settlement details.

Key Figures

10b5-1 sale: 28,826 shares Proceeds (06/30/2026): $462,288.02 10b5-1 sale: 4,170 shares +3 more

6 metrics

10b5-1 sale 28,826 shares 06/30/2026

Proceeds (06/30/2026) $462,288.02 Sale on 06/30/2026

10b5-1 sale 4,170 shares 06/01/2026

Proceeds (06/01/2026) $54,862.19 Sale on 06/01/2026

Option exercise 5,350 shares 07/01/2026

Restricted Stock Units 4,170 RSUs 05/09/2017

Key Terms

10b5-1 plan, Form 144, Restricted Stock Units, Exercise of Stock Options

4 terms

10b5-1 plan regulatory

"10b5-1 Sales for DANIEL LORRAIN"

A 10b5-1 plan is a pre-arranged strategy that allows company insiders to buy or sell their shares at predetermined times and prices, even while they are aware of confidential information. It acts like a scheduled appointment for trading, helping ensure transactions happen transparently and legally, which can reassure investors that trades are not based on insider knowledge.

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 4170 | 05/09/2017"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Exercise of Stock Options financial

"Exercise of Stock Options | Issuer | 5350 | 07/01/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What Form 144 sales did CTNM report?

The filing lists multiple sales under a 10b5-1 plan, including 28,826 shares on 06/30/2026 for $462,288.02, and three prior monthly sales of 4,170 shares each in April–June 2026.

Who initiated the reported sales for CTNM?

The excerpt names Daniel Lorrain as the 10b5-1 plan participant, with address information shown and sales executed on the dates listed in the filing.

Does the filing show any option exercises or RSU items for CTNM?

Yes. The filing records an exercise of stock options for 5,350 shares on 07/01/2026 and lists 4,170 Restricted Stock Units dated 05/09/2017.

Are proceeds or cash‑flow recipients specified in the Form 144 excerpt?

The filing shows gross sale proceeds per trade (e.g., $462,288.02 on 06/30/2026), but it does not state who receives proceeds or settlement mechanics in the provided excerpt.

Does CTNM’s Form 144 indicate these trades were pre‑planned?

Yes. Each sale is labeled as executed under a 10b5-1 plan, which indicates pre‑arranged trading instructions for the dates shown in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 04:34 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001861550
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Contineum Therapeutics, Inc.
SEC File Number	001-42001
Address of Issuer	3565 General Atomics Court, Suite 200 San Diego CALIFORNIA 92121
Phone	8583335280
Name of Person for Whose Account the Securities are To Be Sold	Daniel Lorrain
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	9520	156032.80	32723877	07/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2026	Exercise of Stock Options	Issuer			5350	07/01/2026	Cash
Common	05/09/2017	Restricted Stock Units	Issuer			4170	05/09/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	06/30/2026	28826	462288.02
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	06/01/2026	4170	54862.19
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	05/01/2026	4170	54707.48
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	04/06/2026	4170	56013.94

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	07/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/23/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Lorrain
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)